Skip to content

Research at St Andrews

Morphology-specific inhibition of β-amyloid aggregates by 17β-hydroxysteroid dehydrogenase type 10

Research output: Contribution to journalArticle


A major hallmark of Alzheimer's disease (AD) is the formation of toxic aggregates composed of the β-amyloid peptide (Aβ). Given that Aβ peptides are known to co-localize within mitochondria and interact with 17β-HSD10, a mitochondrial protein expressed at high levels in AD brains, we have investigated the inhibitory potential of 17β-HSD10 against Aβ aggregation across a range of physiological conditions. The fluorescence self-quenching (FSQ) of Aβ(1-42), labelled with HiLyte Fluor 555, was used as a sensing strategy to evaluate the inhibitory effect of 17β-HSD10 under well-established conditions to grow distinct Aβ morphologies. Our results indicate that 17β-HSD10 preferentially inhibits the formation of globular and fibrillar-like structures but has no effect on the growth of amorphous plaque-like aggregates at endosomal pH 6. This work provides insights into the dependence of the Aβ-17β-HSD10 interaction with the morphology of Aβ aggregates and how this impacts enzymatic function.


Original languageEnglish
Pages (from-to)1029-1037
Issue number11
Early online date25 Apr 2016
Publication statusPublished - 2 Jun 2016

    Research areas

  • β-Amyloid peptide, 17β-hydroxysteroid dehydrogenase type 10, Alzheimer's disease, Fluorescence self-quenching, neurochemistry

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Real-time observation of conformational switching in single conjugated polymer chains

    Tenopala Carmona, F., Fronk, S., Bazan, G. C., Samuel, I. D. W. & Penedo-Esteiro, J. C., 16 Feb 2018, In : Science Advances. 4, 2, 13 p., eaao5786.

    Research output: Contribution to journalArticle

  2. 1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders

    Benek, O., Hroch, L., Aitken, L., Gunn-Moore, F., Vinklarova, L., Kuca, K., Perez, D. I., Perez, C., Martinez, A., Fisar, Z. & Musilek, K., 2018, In : Journal of Enzyme Inhibition and Medicinal Chemistry. 33, 1, p. 665-670 6 p.

    Research output: Contribution to journalArticle

  3. In vitro assay development and HTS of small molecule human ABAD/17β-HSD10 inhibitors as therapeutics in Alzheimer’s Disease

    Aitken, L., Baillie, G., Pannifer, A., Morrison, A., Jones, P. S., Smith, T. K., McElroy, S. P. & Gunn-Moore, F. J., Jul 2017, In : SLAS Discovery. 22, 6, p. 676-685 11 p.

    Research output: Contribution to journalArticle

  4. 6-benzothiazolyl ureas, thioureas and guanidines are potent inhibitors of ABAD/17β-HSD10 and potential drugs for Alzheimer's disease treatment: design, synthesis and in vitro evaluation

    Benek, O., Hroch, L., Aitken, L., Dolezal, R., Guest, P., Benkova, M., Soukup, O., Musil, K., Hughes, R., Kuca, K., Smith, T. K., Gunn-Moore, F. & Musilek, K., Jun 2017, In : Medicinal Chemistry. 13, 4, p. 345-358 14 p.

    Research output: Contribution to journalArticle

  5. Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer’s disease treatment

    Hroch, L., Guest, P., Benek, O., Soukup, O., Janockova, J., Dolezal, R., Kuca, K., Aitken, L., Smith, T. K., Gunn-Moore, F., Zala, D., Ramsay, R. R. & Musilek, K., 1 Feb 2017, In : Bioorganic & Medicinal Chemistry. 25, 3, p. 1143-1152 10 p.

    Research output: Contribution to journalArticle

Related by journal

  1. Acetyl coenzyme A analogues as rationally designed inhibitors of citrate synthase

    Bello, D., Rubanu, M. G., Bandaranayaka, N., Götze, J. P., Bühl, M. & O'Hagan, D., 29 Mar 2019, In : ChemBioChem. Early View

    Research output: Contribution to journalArticle

  2. Enzymatic fluorination of biotin and tetrazine conjugates for pretargeting approaches to PET imaging

    Lowe, P. T., Dall'angelo, S., Devine, A., Zanda, M. & O'Hagan, D., 8 Aug 2018, In : ChemBioChem. In press

    Research output: Contribution to journalArticle

  3. A novel class of fluorinated A2A adenosine receptor agonist with application to last step enzymatic [18F]fluorination for PET imaging

    Lowe, P. T., Dall'Angello, S., Mulder-Krieger, T., Ijzerman, A. P., Zanda, M. & O'Hagan, D., 2 Nov 2017, In : ChemBioChem. 18, 21, p. 2156-2164

    Research output: Contribution to journalArticle

  4. Structure and substrate recognition of the Bottromycin maturation enzyme BotP

    Mann, G., Huo, L., Adam, S., Nardone, B., Vendome, J., Westwood, N. J., Müller, R. & Koehnke, J., 2 Dec 2016, In : ChemBioChem. 17, 23, p. 2286-2292 7 p.

    Research output: Contribution to journalArticle

ID: 241406601